Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas

Area of Science:

• Gastroenterology
• Molecular Biology
• Oncology

Background:

• Gallbladder carcinoma pathogenesis is complex, with dysplasia and carcinoma in situ as known precursors.
• The role of gallbladder adenomas in gallbladder carcinoma development remains debated.
• Molecular alterations like loss of heterozygosity (LOH) and gene mutations are observed in gallbladder dysplasia and carcinoma.

Purpose of the Study:

• To investigate if gallbladder adenomas share molecular abnormalities with gallbladder carcinomas.
• To compare the molecular profiles of gallbladder adenomas with those of known precancerous lesions.

Main Methods:

• DNA was extracted from 16 gallbladder adenomas (14 pyloric, 2 intestinal-type).
• Analysis included mutations in TP53, K-ras, and N-ras genes.
• Loss of heterozygosity (LOH) was assessed at five chromosomal regions (5q22, RB, TP53, DCC, 9p21).
• TP53 mutations were detected using single-strand conformational polymorphism (SSCP).
• K-ras and N-ras mutations were identified via restriction fragment length polymorphism (RFLP) and sequencing.

Main Results:

• Only one instance of LOH at 5q22 was found in an intestinal-type adenoma.
• No TP53 mutations were detected in any adenomas.
• K-ras mutations were present in 25% of adenomas (two at codon 12, two at codon 61).

Conclusions:

• Gallbladder adenomas do not exhibit the common molecular changes found in dysplasia, carcinoma in situ, and invasive gallbladder carcinoma.
• The presence of K-ras mutations in a subset of adenomas suggests they are unlikely to be direct precursors to invasive gallbladder carcinoma.